Express Specialty Pharmacy
Quick facts
Marketed products
- Prilocaine 2.5% · Anesthesia
Prilocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.
Phase 2 pipeline
- baclofen 2%
- Bupivacaine hydrochloride 1% · Oncology
Local anesthetic by blocking sodium channels - Capsaicin, USP 0.0375% · Pain Management
Activates TRPV1 receptors - Cyclobenzaprine hydrochloride 2% · Musculoskeletal/Pain Management
Cyclobenzaprine is a centrally acting muscle relaxant that reduces muscle tension by depressing activity in the brainstem. - Flurbiprofen 10%
- Gabapentin 6%
- Ketamine 10% · Anesthesiology
NMDA receptor antagonist - Meloxicam 0.09%
- Menthol, NF 5.00 %
- Sumatriptan 5%
- Tizanidine 0.1%
- Topiramate 2.5%
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Express Specialty Pharmacy
What are Express Specialty Pharmacy's marketed drugs?
Top marketed products include Prilocaine 2.5%.
Related
- Prilocaine 2.5% · Anesthesia
- Sector hub: All tracked pharma companies